Why cannabis can affect anxiety at all

Your body has an internal balancing network called the endocannabinoid system (ECS), involved in mood, stress response, sleep, and more. Cannabinoids like THC and CBD interact with this system (directly or indirectly), which is why cannabis can shift how you experience stress—sometimes toward calm, sometimes the opposite.

The “sometimes the opposite” part matters: the CDC notes cannabis can cause unpleasant thoughts or feelings of anxiety and paranoia for some people.

Dry-ish January isn’t about being perfect—it’s about being intentional. Maybe you’re cutting back on alcohol, skipping it on weeknights, or just trying to wake up in January feeling like yourself instead of a dehydrated raccoon. If you’re a Florida medical marijuana patient, low-dose cannabis can fit that same “less, but better” mindset—especially when you choose formats that make moderation easy.

What a COA is (and why it matters in cannabis Florida)

A COA is a third-party lab report tied to a specific batch (also called lot) of a product. It typically covers two big things:

1. Potency (cannabinoids like THC/CBD, sometimes terpenes)

2. Safety (screens for contaminants like pesticides, heavy metals, microbials, residual solvents, etc.)

In Florida’s medical program, testing labs are certified through the state’s Office of Medical Marijuana Use (OMMU), and OMMU publishes a list of certified marijuana testing laboratories (CMTLs).

The biggest 2025 headline: Rescheduling is back in motion

Late in 2025, President Donald Trump signed an executive order directing the Department of Justice to move more quickly on the ongoing process to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.

That’s a big deal in cannabis policy terms—but it’s not the same as federal legalization.

Key point: Multiple legal and policy summaries emphasize that a final rule has not been issued, and until it is, marijuana remains Schedule I at the federal level.